Metraipolis › archive › dc_5fdaa581dd17

PARPs and PARP inhibitors: molecular mechanisms and clinical applications — Europe PMC PMID:41460301

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41460301
DOI
10.1186/s43556-[numero omesso]-1
License (as archived)
solo-consultazione
Archived
2026-11-07T08:23:16.845Z
SHA-256 of the archived text
ac48e087fb6cd37c1fa4910a3a86e7d1c2c367693c2456f313d25ebdb352f05d
Stable URL of this page
https://metraipolis.com/documento/dc_5fdaa581dd17

How to cite

PARPs and PARP inhibitors: molecular mechanisms and clinical applications — Europe PMC PMID:41460301 — Europe PMC (en), https://europepmc.org/article/MED/41460301 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5fdaa581dd17 (Metraipolis archive dc_5fdaa581dd17, sha256 ac48e087fb6cd37c1fa4910a3a86e7d1c2c367693c2456f313d25ebdb352f05d)
BibTeX
@misc{dc5fdaa581dd17,
  title = {PARPs and PARP inhibitors: molecular mechanisms and clinical applications — Europe PMC PMID:41460301},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41460301},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5fdaa581dd17; sha256 ac48e087fb6cd37c1fa4910a3a86e7d1c2c367693c2456f313d25ebdb352f05d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41460301. Agents can read the archived copy with the MCP tool read_document.